Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid

Journal of Clinical Investigation

Volumn 116, Issue 10, 2006, Pages 2622-2632

  Marinkovic, Tatjana ^a   Garin, Alexandre ^a   Yokota, Yoshifumi ^b   Fu, Yang Xin ^c   Ruddle, Nancy H ^d   Furtado, Glaucia C ^a   Lira, Sergio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR7; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; GENE; GENE DELETION; ID2 GENE; LYMPHOID CELL; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID GLAND;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD3; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL MOVEMENT; CHEMOKINE CCL21; CHEMOKINES; CHEMOKINES, CC; DENDRITIC CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; LYMPHOID TISSUE; LYMPHOTOXIN-ALPHA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CCR7; RECEPTORS, CHEMOKINE; THYROID DISEASES; THYROID GLAND;

EID: 33749425111     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28993     Document Type: Article

References (68)

1. Mebius, R.E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3:292-303.
2. Drayton, D.L., Liao, S., Mounzer, R.H., and Ruddle, N.H. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7:344-353.
3. Eberl, G., and Littman, D.R. 2003. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195:81-90.
4. Yokota, Y., et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:702-706.
5. Kim, D., et al. 2000. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192:1467-1478.
6. Muller, G., and Lipp, M. 2003. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr. Opin. Immunol. 15:217-224.
7. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M.H., and Pfeffer, K. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:59-70.
8. Rennert, P.D., James, D., Mackay, F., Browning, J.L., and Hochman, P.S. 1998. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity. 9:71-79.
9. De Togni, P., et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:703-707.
10. Koni, P.A., et al. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity. 6:491-500.
11. Soderberg, K.A., Linehan, M.M., Ruddle, N.H., and Iwasaki, A. 2004. MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection. J. Immunol. 173:1908-1913.
12. Rennert, P.D., Browning, J.L., and Hochman, P.S. 1997. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int. Immunol. 9:1627-1639.
13. Scheu, S., et al. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 195:1613-1624.
14. Rot, A., and von Andrian, U.H. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928.
15. Miyasaka, M., and Tanaka, T. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360-370.
16. Drayton, D.L., et al. 2002. Lymphocyte traffic in lymphoid organ neogenesis: differential roles of Ltalpha and LTalphabeta. Adv. Exp. Med. Biol. 512:43-48.
17. Ying, X., Chan, K., Shenoy, P., Hill, M., and Ruddle, N.H. 2005. Lymphotoxin plays a crucial role in the development and function of nasal-associated lymphoid tissue through regulation of chemokines and peripheral node addressin. Am. J. Pathol. 166:135-146.
18. Drayton, D.L., Ying, X., Lee, J., Lesslauer, W., and Ruddle, N.H. 2003. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197:1153-1163.
19. Browning, J.L., et al. 2005. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity. 23:539-550.
20. Aloisi, F., and Pujol-Borrell, R. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6:205-217.
21. Cupedo, T., and Mebius, R.E. 2003. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin. Immunol. 15:243-248.
22. Fan, L., Reilly, C.R., Luo, Y., Dorf, M.E., and Lo, D. 2000. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164:3955-3959.
23. Chen, S.C., et al. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001-1008.
24. Martin, A.P., et al. 2004. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 173:4791-4798.
25. Luther, S.A., Lopez, T., Bai, W., Hanahan, D., and Cyster, J.G. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 12:471-481.
26. Luther, S.A., et al. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-433.
27. Cupedo, T., Jansen, W., Kraal, G., and Mebius, R.E. 2004. Induction of secondary and tertiary lymphoid structures in the skin. Immunity. 21:655-667.
28. Fukuyama, S., et al. 2002. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity. 17:31-40.
29. Manfra, D.J., et al. 2001. Leukocytes expressing green fluorescent protein as novel reagents for adoptive cell transfer and bone marrow transplantation studies. Am. J. Pathol. 158:41-47.
30. Forster, R., et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:23-33.
31. Manfra, D.J., et al. 2003. Conditional expression of murine Flt3 ligand leads to expansion of multiple dendritic cell subsets in peripheral blood and tissues of transgenic mice. J. Immunol. 170:2843-2852.
32. Park, M.K., et al. 2002. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169:1433-1443.
33. Garcia-Lopez, M.A., et al. 2001. CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab. Invest. 81:409-418.
34. Bleul, C.C., Schultze, J.L., and Springer, T.A. 1998. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J. Exp. Med. 187:753-762.
35. MartIn-Fontecha, A., et al. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621.
36. Wu, Q., et al. 1999. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190:629-638.
37. Browning, J.L., et al. 1997. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 159:3288-3298.
38. Hemmerich, S., et al. 2001. Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity. 15:237-247.
39. Bistrup, A., et al. 2004. Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope. Am. J. Pathol. 164:1635-1644.
40. Armengol, M.P., et al. 2003. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170:6320-6328.
41. Kim, M.Y., et al. 2003. CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity. 18:643-654.
42. Debes, G.F., et al. 2005. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6:889-894.
43. Bromley, S.K., Thomas, S.Y., and Luster, A.D. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6:895-901.
44. Gunn, M.D., et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-460.
45. Bjorkdahl, O., et al. 2003. Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues. Immunology. 110:170-179.
46. Muller, G., Reiterer, P., Hopken, U.E., Golfier, S., and Lipp, M. 2003. Role of homeostatic chemokine and sphingosine-1-phosphate receptors in the organization of lymphoid tissue. Ann. N. Y. Acad. Sci. 987:107-116.
47. Carr, M.W., Roth, S.J., Luther, E., Rose, S.S., and Springer, T.A. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U. S. A. 91:3652-3656.
48. Osterholzer, J.J., et al. 2005. CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J. Immunol. 175:874-883.
49. Tabata, S., et al. 2005. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells. J. Leukoc. Biol. 77:777-786.
50. Shimaoka, T., et al. 2003. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 171:1647-1651.
51. Kemp, E.H., et al. 2003. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.). 59:207-213.
52. Rotondi, M., Lazzeri, E., Romagnani, P., and Serio, M. 2003. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J. Endocrinol. Invest. 26:177-180.
53. Romagnani, P., et al. 2002. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am. J. Pathol. 161:195-206.
54. Garcia-Lopez, M.A., Sancho, D., Sanchez-Madrid, F., and Marazuela, M. 2001. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J. Clin. Endocrinol. Metab. 86:5008-5016.
55. Van Dinther-Janssen, A.C., Pals, S.T., Scheper, R., Breedveld, F., and Meijer, C.J. 1990. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J. Rheumatol. 17:11-17.
56. Middel, P., Raddatz, D., Gunawan, B., Haller, F., and Radzun, H.J. 2005. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine-mediated retention mechanism. Gut. 55:220-227.
57. Feuillet, V., Lucas, B., Di Santo, J.P., Bismuth, G., and Trautmann, A. 2005. Multiple survival signals are delivered by dendritic cells to naive CD4(+) T cells. Eur. J. Immunol. 35:2563-2572.
58. Drayton, D.L., et al. 2004. I kappa B kinase complex alpha kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J. Immunol. 173:6161-6168.
59. Kabashima, K., et al. 2005. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity. 22:439-450.
60. Ware, C.F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23:787-819.
61. Weetman, A.P., and McGregor, A.M. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15:788-830.
62. Wicker, L.S., Todd, J.A., and Peterson, L.B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200.
63. Humphreys, T.L., Baldridge, L.A., Billings, S.D., Campbell, J.J., and Spinola, S.M. 2005. Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi. Infect. Immun. 73:3896-3902.
64. Kurt, R.A., Brault, M.S., and Fried, B. 2003. Evidence of altered secondary lymphoid-tissue chemokine responsiveness in Balb/c mice infected with Schistosoma mansoni. J. Parasitol. 89:721-725.
65. Bonacchi, A., et al. 2003. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology. 125:1060-1076.
66. Khoruts, A., and Fraser, J.M. 2005. A causal link between lymphopenia and autoimmunity. Immunol. Lett. 98:23-31.
67. Korner, H., et al. 1997. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600-2609.
68. Rennert, P.D., Browning, J.L., Mebius, R., Mackay, F., and Hochman, P.S. 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999-2006.